2028 年亞太地區生物製程技術市場預測 - 按類型、模式和最終用戶進行的區域分析
市場調查報告書
商品編碼
1375195

2028 年亞太地區生物製程技術市場預測 - 按類型、模式和最終用戶進行的區域分析

Asia Pacific Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: | 出版商: The Insight Partners | 英文 141 Pages | 訂單完成後即時交付

價格

亞太生物製程技術市場預計將從2023年的46.0864億美元成長到2028年的110.075億美元。預計2023年至2028年年複合成長率為19.0%。

自動即時流式細胞儀 (ART-FCM) 的出現推動亞太生物製程技術市場

流式細胞儀 (FCM) 及其技術可能性在過去十年中取得了巨大進步,作為生物反應器中單細胞特性和不同細胞類型群體分佈的分析工具。在此過程中,開發了一些自動化即時流式細胞儀 (ART-FCM) 解決方案,用於監測生物反應器過程,而無需操作員長時間干擾,且採樣頻率可變。 ART-FCM 能夠實現長期測量,不會錯過生物過程中的任何重要事件,並揭示可能未知且應進行更詳細研究的時間現象。此外,可以按照使用者定義的頻率執行更頻繁的測量,而與人員的可用性無關。與僅在單細胞層級上部分可用的組學等方法相比,透過 ART-FCM 可以輕鬆建立多參數測量,而無需花費大量的人力和時間。與傳統的FCM研究相比,微流控元件作為晶片上的ART-FCM具有巨大的未來潛力。在這種情況下,並行化可能變得更加相關,因為可以同時分析來自不同生物反應器或生物反應器設定內不同位置的樣本。許多方面也可能適用於其他實驗設置,其中螢光過程參數的快速且可重複的即時監測也令人感興趣。總之,ART-FCM 很可能在未來幾年呈指數級發展。

亞太地區生物製程技術市場概況

根據 BioPlan Associates 1000 強生物設施指數和生物製造商資料庫報告,自過去十年以來,全球生物加工能力平均增加了 12%。中國作為小分子藥物和大分子藥物市場的全球參與者處於有利地位,分別佔據全球第二和第三位。此外,由於中國擁有合約開發和製造組織 (CDMO) 基地,約佔該國生物產能的 25%,中國也是多家細胞和基因治療開發商的所在地。因此,中國擁有相當大的生物製造能力,但嚴格遵守全球GMP標準,這對生物製劑的安全性和有效性建立了信心。

亞太地區生物製程技術市場收入及 2028 年預測(百萬美元)

亞太地區生物製程技術市場細分

亞太生物製程技術市場按類型、模式、最終用戶和國家進行細分。

根據類型,亞太生物製程技術市場分為細胞培養基生物製程、色譜生物製程、消耗品和配件等。 2023年,耗材及配件領域在亞太生物製程技術市場中佔據最大佔有率。

根據模式,亞太生物製程技術市場分為一次性和多次使用。 2023年,一次性細分市場在亞太生物製程技術市場中佔據更大佔有率。

根據最終用途,亞太生物製程技術市場分為學術和醫療機構、生物製藥公司、研究實驗室等。 2023年,生物製藥公司細分市場在亞太生物製程技術市場中佔據最大佔有率。

依國家/地區分類,亞太地區生物製程技術市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2023年,中國市場在亞太生物製程技術市場中佔據最大佔有率。

康寧公司;丹納赫公司;艾本德公司;龍沙集團股份公司;默克公司;雷普利根公司;賽多利斯公司;和 Thermo Fisher Scientific Inc 是亞太地區生物製程技術市場上的一些領先公司。

目錄

第 1 章:簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 亞太地區生物製程技術市場 - 按類型
    • 亞太生物製程技術市場 - 按模式
    • 亞太生物製程技術市場 - 按最終用戶分類
    • 亞太生物製程技術市場 - 按國家/地區

第 2 章:亞太地區生物製程技術市場 - 要點

第 3 章:研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章:亞太地區生物製程技術市場 - 市場格局

  • 概述
  • 亞太地區 PEST 分析
  • 專家意見

第 5 章:亞太地區生物製程技術市場 - 主要市場動態

  • 市場促進因素
    • 不斷增加研發支出以推出新藥物化合物
    • 慢性病盛行率增加
  • 市場限制
    • 嚴格的監理政策
  • 市場機會
    • 引進先進的生物製程技術
  • 未來的趨勢
    • 自動即時流式細胞儀 (ART-FCM) 的出現
  • 影響分析

第 6 章:生物製程技術市場 - 亞太地區分析

  • 亞太地區生物製程技術市場收入預測與分析

第 7 章:亞太地區生物製程技術市場 - 收入和 2028 年預測 - 按類型

  • 概述
  • 2022 年及 2028 年生物製程技術市場收入佔有率,按類型分類 (%)
  • 細胞培養基生物過程
  • 色譜生物過程
  • 耗材及配件
  • 其他

第 8 章:2028 年亞太地區生物製程技術市場分析與預測 - 按模式

  • 概述
  • 亞太地區生物製程技術市場,按模式 2022 年和 2028 年 (%)
  • 單人使用
  • 多次使用

第 9 章:亞太地區生物製程技術市場 - 收入和 2028 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2028 年亞太地區生物製程技術市場收入佔有率(按最終用戶分類)(%)
  • 學術及醫療機構
  • 生物製藥公司
  • 研究實驗室
  • 其他

第 10 章:亞太地區生物製程技術市場 - 2028 年收入與預測 - 國家分析

    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳洲
      • 亞太地區其他地區

第 11 章:亞太地區生物製程技術市場 - 產業格局

  • 概述
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章:公司簡介

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp

第 13 章:附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00028868

The Asia Pacific bioprocess technology market is expected to grow from US$ 4,608.64 million in 2023 to US$ 11,000.75 million by 2028. It is estimated to grow at a CAGR of 19.0% from 2023 to 2028.

Emergence of Automated Real-Time Flow Cytometry (ART-FCM) Drive Asia Pacific Bioprocess Technology Market

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated Real-Time Flow Cytometry (ART-FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency. ART-FCM enables s long-term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM. Compared with conventional FCM studies, microfluidic devices great future potential as ART-FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real-time monitoring of fluorescent process parameters is also of interest. In conclusion, ART-FCM will most probably advance exponentially in the upcoming years.

Asia Pacific Bioprocess Technology Market Overview

The bioprocessing capacity globally has increased at an average of 12% since the past decade, as per the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database report. China is well positioned as a global participant in markets with both small and large-molecule drugs, accounting for second and third position, respectively, worldwide. Also, China is home to several developers of cell and gene therapy due to China's base for contract development and manufacturing organizations (CDMOs), accounting for ~25% of the country's bioproduction capacity. Therefore, China has considerable biomanufacturing capabilities but strict adherence to the global GMP standards that build confidence in the biologics' safety and effectiveness.

Asia Pacific Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Bioprocess Technology Market Segmentation

The Asia Pacific bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Asia Pacific bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on modality, the Asia Pacific Bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Asia Pacific bioprocess technology market.

Based on end-use, the Asia Pacific Bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on country, the Asia Pacific Bioprocess technology market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China segment registered a largest share in the Asia Pacific bioprocess technology market.

Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bioprocess technology market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Bioprocess Technology Market - by Type
    • 1.3.2 Asia Pacific Bioprocess Technology Market - by Modality
    • 1.3.3 Asia Pacific Bioprocess Technology Market - by End User
    • 1.3.4 Asia Pacific Bioprocess Technology Market - by Country

2. Asia Pacific Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Bioprocess Technology Market Revenue Forecast and Analysis

7. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatography Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatography Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Bioprocess Technology Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sartorius AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Thermo Fisher Scientific Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Corning Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lonza Group AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Repligen Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Danaher Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
  • Table 2. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 21. Recent Inorganic Growth Strategies in the Asia Pacific bioprocess technology market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Bioprocess Technology Market Segmentation
  • Figure 2. Asia Pacific Bioprocess Technology Market, by Country
  • Figure 3. Asia Pacific Bioprocess Technology Market Overview
  • Figure 4. Others Segment Held Largest Share of Type Segment in Asia Pacific Bioprocess Technology Market
  • Figure 5. India Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Asia Pacific Bioprocess Technology Market Impact and Analysis
  • Figure 9. Asia Pacific Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 11. Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Chromatographic Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 16. Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 19. Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)